Login / Signup

A cytosine deaminase for programmable single-base RNA editing.

Omar O AbudayyehJonathan Samuel GootenbergBrian FranklinJeremy KoobMax J KellnerAlim LadhaJulia JoungPaul KirchgattererDavid B T CoxFeng Zhang
Published in: Science (New York, N.Y.) (2019)
Programmable RNA editing enables reversible recoding of RNA information for research and disease treatment. Previously, we developed a programmable adenosine-to-inosine (A-to-I) RNA editing approach by fusing catalytically inactivate RNA-targeting CRISPR-Cas13 (dCas13) with the adenine deaminase domain of ADAR2. Here, we report a cytidine-to-uridine (C-to-U) RNA editor, referred to as RNA Editing for Specific C-to-U Exchange (RESCUE), by directly evolving ADAR2 into a cytidine deaminase. RESCUE doubles the number of mutations targetable by RNA editing and enables modulation of phosphosignaling-relevant residues. We apply RESCUE to drive β-catenin activation and cellular growth. Furthermore, RESCUE retains A-to-I editing activity, enabling multiplexed C-to-U and A-to-I editing through the use of tailored guide RNAs.
Keyphrases
  • crispr cas
  • genome editing
  • nucleic acid
  • healthcare
  • cell proliferation
  • drug delivery
  • epithelial mesenchymal transition
  • social media
  • signaling pathway
  • combination therapy
  • replacement therapy